Invest in 5,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California. more
Time Frame | BNGO | Sector | S&P500; |
---|---|---|---|
1-Week Return | -23.57% | -1.82% | -3.38% |
1-Month Return | -22.82% | -4.41% | -2.74% |
3-Month Return | -35.48% | -0.32% | 5.38% |
6-Month Return | -57.45% | 7.48% | 17.24% |
1-Year Return | -89.51% | 5.37% | 22.71% |
3-Year Return | -98.51% | 19.39% | 26.18% |
5-Year Return | -98.11% | 75.65% | 87.58% |
10-Year Return | -98.87% | 182.56% | 222.4% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 10.13M | 8.50M | 17.98M | 27.80M | 36.12M | [{"date":"2019-12-31","value":28.05,"profit":true},{"date":"2020-12-31","value":23.54,"profit":true},{"date":"2021-12-31","value":49.79,"profit":true},{"date":"2022-12-31","value":76.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 6.77M | 5.73M | 14.11M | 21.86M | 26.55M | [{"date":"2019-12-31","value":25.49,"profit":true},{"date":"2020-12-31","value":21.58,"profit":true},{"date":"2021-12-31","value":53.13,"profit":true},{"date":"2022-12-31","value":82.32,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 3.36M | 2.77M | 3.87M | 5.95M | 9.57M | [{"date":"2019-12-31","value":35.14,"profit":true},{"date":"2020-12-31","value":28.99,"profit":true},{"date":"2021-12-31","value":40.5,"profit":true},{"date":"2022-12-31","value":62.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 33.18% | 32.61% | 21.54% | 21.38% | 26.49% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.27,"profit":true},{"date":"2021-12-31","value":64.93,"profit":true},{"date":"2022-12-31","value":64.44,"profit":true},{"date":"2023-12-31","value":79.82,"profit":true}] |
Operating Expenses | 29.24M | 41.32M | 80.97M | 137.64M | 148.99M | [{"date":"2019-12-31","value":19.62,"profit":true},{"date":"2020-12-31","value":27.74,"profit":true},{"date":"2021-12-31","value":54.35,"profit":true},{"date":"2022-12-31","value":92.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (25.87M) | (38.55M) | (77.10M) | (131.70M) | (139.43M) | [{"date":"2019-12-31","value":-2587490600,"profit":false},{"date":"2020-12-31","value":-3855132200,"profit":false},{"date":"2021-12-31","value":-7710100000,"profit":false},{"date":"2022-12-31","value":-13169800000,"profit":false},{"date":"2023-12-31","value":-13942700000,"profit":false}] |
Total Non-Operating Income/Expense | (6.23M) | (5.07M) | (1.74M) | 2.19M | (94.81M) | [{"date":"2019-12-31","value":-283.66,"profit":false},{"date":"2020-12-31","value":-231.16,"profit":false},{"date":"2021-12-31","value":-79.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4319.45,"profit":false}] |
Pre-Tax Income | (29.82M) | (41.11M) | (78.15M) | (130.71M) | (232.43M) | [{"date":"2019-12-31","value":-2981507000,"profit":false},{"date":"2020-12-31","value":-4110635100,"profit":false},{"date":"2021-12-31","value":-7815200000,"profit":false},{"date":"2022-12-31","value":-13071200000,"profit":false},{"date":"2023-12-31","value":-23243100000,"profit":false}] |
Income Taxes | 21.05K | 29.19K | (5.72M) | 1.88M | 62.00K | [{"date":"2019-12-31","value":1.12,"profit":true},{"date":"2020-12-31","value":1.55,"profit":true},{"date":"2021-12-31","value":-303.45,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.29,"profit":true}] |
Income After Taxes | (29.84M) | (41.14M) | (72.44M) | (132.60M) | (232.49M) | [{"date":"2019-12-31","value":-2983611800,"profit":false},{"date":"2020-12-31","value":-4113554400,"profit":false},{"date":"2021-12-31","value":-7243500000,"profit":false},{"date":"2022-12-31","value":-13259600000,"profit":false},{"date":"2023-12-31","value":-23249300000,"profit":false}] |
Income From Continuous Operations | (29.82M) | (41.11M) | (72.44M) | (132.60M) | (232.49M) | [{"date":"2019-12-31","value":-2981507000,"profit":false},{"date":"2020-12-31","value":-4110635100,"profit":false},{"date":"2021-12-31","value":-7243500000,"profit":false},{"date":"2022-12-31","value":-13259600000,"profit":false},{"date":"2023-12-31","value":-23249300000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (29.84M) | (41.14M) | (72.44M) | (132.60M) | (232.49M) | [{"date":"2019-12-31","value":-2983611800,"profit":false},{"date":"2020-12-31","value":-4113554400,"profit":false},{"date":"2021-12-31","value":-7243500000,"profit":false},{"date":"2022-12-31","value":-13259600000,"profit":false},{"date":"2023-12-31","value":-23249300000,"profit":false}] |
EPS (Diluted) | (2.37) | (0.52) | (0.25) | (0.46) | (3.32) | [{"date":"2019-12-31","value":-237,"profit":false},{"date":"2020-12-31","value":-52,"profit":false},{"date":"2021-12-31","value":-25,"profit":false},{"date":"2022-12-31","value":-46,"profit":false},{"date":"2023-12-31","value":-331.93,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
BNGO | |
---|---|
Cash Ratio | 1.02 |
Current Ratio | 1.40 |
Quick Ratio | 1.17 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BNGO | |
---|---|
ROA (LTM) | -33.39% |
ROE (LTM) | -134.56% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BNGO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.55 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.45 |
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. | 2.23 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BNGO | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.66 |
P/B | 0.62 |
Price/FCF | NM |
EV/R | 1.03 |
EV/Ebitda | NM |
PEG | 0.00 |
The latest announcement is out from BioNano Genomics Inc (BNGO). Bionano Genomics, Inc. has initiated a registered direct offering, securing an agr…
Bionano Genomics (BNGO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Bionano Genomics encountered a significant busi…
BNGO earnings call for the period ending December 31, 2023.
Q4 2023 Bionano Genomics Inc Earnings Call Transcript
Bionano Genomics (NASDAQ: BNGO ) just reported results for the fourth quarter of 2023. Bionano Genomics reported earnings per share of -96 cents. This was below the analyst estimate for EPS of -87 cents. The company reported revenue of $10.72 million. This was 1.33% better than the analyst estimate for revenue of $10.58 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
Bionano Genomics Inc (BNGO) share price today is $0.7872
Yes, Indians can buy shares of Bionano Genomics Inc (BNGO) on Vested. To buy Bionano Genomics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BNGO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Bionano Genomics Inc (BNGO) via the Vested app. You can start investing in Bionano Genomics Inc (BNGO) with a minimum investment of $1.
You can invest in shares of Bionano Genomics Inc (BNGO) via Vested in three simple steps:
The 52-week high price of Bionano Genomics Inc (BNGO) is $8.2. The 52-week low price of Bionano Genomics Inc (BNGO) is $0.79.
The price-to-earnings (P/E) ratio of Bionano Genomics Inc (BNGO) is NM
The price-to-book (P/B) ratio of Bionano Genomics Inc (BNGO) is 0.62
The dividend yield of Bionano Genomics Inc (BNGO) is 0.00%
The market capitalization of Bionano Genomics Inc (BNGO) is $43.06M
The stock symbol (or ticker) of Bionano Genomics Inc is BNGO